nodes	percent_of_prediction	percent_of_DWPC	metapath
Propranolol—HTR1B—attention deficit hyperactivity disorder	0.791	1	CbGaD
Propranolol—ORM1—saliva—attention deficit hyperactivity disorder	0.00486	0.219	CbGeAlD
Propranolol—Naphazoline—ADRA2C—attention deficit hyperactivity disorder	0.00193	0.21	CrCbGaD
Propranolol—HTR1B—forebrain—attention deficit hyperactivity disorder	0.00109	0.0489	CbGeAlD
Propranolol—ADRB1—forebrain—attention deficit hyperactivity disorder	0.00102	0.046	CbGeAlD
Propranolol—Carvedilol—ADRA2C—attention deficit hyperactivity disorder	0.000952	0.104	CrCbGaD
Propranolol—Bopindolol—HTR1B—attention deficit hyperactivity disorder	0.00093	0.101	CrCbGaD
Propranolol—HTR1B—cardiovascular system—attention deficit hyperactivity disorder	0.000919	0.0413	CbGeAlD
Propranolol—Penbutolol—HTR1B—attention deficit hyperactivity disorder	0.000887	0.0967	CrCbGaD
Propranolol—HTR1A—forebrain—attention deficit hyperactivity disorder	0.000877	0.0394	CbGeAlD
Propranolol—ADRB1—cardiovascular system—attention deficit hyperactivity disorder	0.000865	0.0389	CbGeAlD
Propranolol—Naphazoline—ADRA2A—attention deficit hyperactivity disorder	0.000823	0.0897	CrCbGaD
Propranolol—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.000742	0.0334	CbGeAlD
Propranolol—HTR1B—midbrain—attention deficit hyperactivity disorder	0.000718	0.0323	CbGeAlD
Propranolol—Pindolol—HTR1B—attention deficit hyperactivity disorder	0.000639	0.0697	CrCbGaD
Propranolol—Duloxetine—SLC6A3—attention deficit hyperactivity disorder	0.000633	0.069	CrCbGaD
Propranolol—ORM1—nervous system—attention deficit hyperactivity disorder	0.00063	0.0283	CbGeAlD
Propranolol—ORM1—central nervous system—attention deficit hyperactivity disorder	0.000606	0.0273	CbGeAlD
Propranolol—HTR1B—nervous system—attention deficit hyperactivity disorder	0.00059	0.0265	CbGeAlD
Propranolol—HTR1A—midbrain—attention deficit hyperactivity disorder	0.000579	0.026	CbGeAlD
Propranolol—HTR1B—central nervous system—attention deficit hyperactivity disorder	0.000568	0.0255	CbGeAlD
Propranolol—ADRB1—nervous system—attention deficit hyperactivity disorder	0.000555	0.025	CbGeAlD
Propranolol—ADRB1—central nervous system—attention deficit hyperactivity disorder	0.000535	0.024	CbGeAlD
Propranolol—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000476	0.0214	CbGeAlD
Propranolol—HTR1A—nervous system—attention deficit hyperactivity disorder	0.000476	0.0214	CbGeAlD
Propranolol—Duloxetine—SLC6A4—attention deficit hyperactivity disorder	0.000474	0.0516	CrCbGaD
Propranolol—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.000459	0.0206	CbGeAlD
Propranolol—HTR1B—brain—attention deficit hyperactivity disorder	0.000451	0.0203	CbGeAlD
Propranolol—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.000448	0.0202	CbGeAlD
Propranolol—ADRB1—brain—attention deficit hyperactivity disorder	0.000424	0.0191	CbGeAlD
Propranolol—Carvedilol—ADRA2A—attention deficit hyperactivity disorder	0.000406	0.0443	CrCbGaD
Propranolol—Atomoxetine—HTR1B—attention deficit hyperactivity disorder	0.000367	0.04	CrCbGaD
Propranolol—HTR1A—brain—attention deficit hyperactivity disorder	0.000364	0.0164	CbGeAlD
Propranolol—Duloxetine—HTR2A—attention deficit hyperactivity disorder	0.000364	0.0397	CrCbGaD
Propranolol—CYP1A1—nervous system—attention deficit hyperactivity disorder	0.000358	0.0161	CbGeAlD
Propranolol—CYP1A1—central nervous system—attention deficit hyperactivity disorder	0.000345	0.0155	CbGeAlD
Propranolol—ABCB1—forebrain—attention deficit hyperactivity disorder	0.000343	0.0154	CbGeAlD
Propranolol—Atomoxetine—SLC6A3—attention deficit hyperactivity disorder	0.000332	0.0362	CrCbGaD
Propranolol—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00029	0.013	CbGeAlD
Propranolol—CYP1A1—brain—attention deficit hyperactivity disorder	0.000274	0.0123	CbGeAlD
Propranolol—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000263	0.0118	CbGeAlD
Propranolol—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000259	0.0116	CbGeAlD
Propranolol—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000253	0.0114	CbGeAlD
Propranolol—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000249	0.0112	CbGeAlD
Propranolol—Atomoxetine—SLC6A4—attention deficit hyperactivity disorder	0.000248	0.027	CrCbGaD
Propranolol—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000243	0.0109	CbGeAlD
Propranolol—ABCB1—midbrain—attention deficit hyperactivity disorder	0.000226	0.0102	CbGeAlD
Propranolol—CYP2D6—brain—attention deficit hyperactivity disorder	0.000198	0.00889	CbGeAlD
Propranolol—Atomoxetine—HTR2A—attention deficit hyperactivity disorder	0.000191	0.0208	CrCbGaD
Propranolol—ABCB1—nervous system—attention deficit hyperactivity disorder	0.000186	0.00836	CbGeAlD
Propranolol—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.000179	0.00805	CbGeAlD
Propranolol—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.000175	0.00787	CbGeAlD
Propranolol—ABCB1—brain—attention deficit hyperactivity disorder	0.000142	0.00639	CbGeAlD
Propranolol—ADRB3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	7.82e-05	0.000441	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	7.72e-05	0.000435	CbGpPWpGaD
Propranolol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	7.7e-05	0.000434	CbGpPWpGaD
Propranolol—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	7.7e-05	0.000434	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	7.68e-05	0.000433	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	7.63e-05	0.000429	CbGpPWpGaD
Propranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	7.56e-05	0.000426	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	7.53e-05	0.000424	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	7.52e-05	0.000423	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	7.44e-05	0.000419	CbGpPWpGaD
Propranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	7.39e-05	0.000416	CbGpPWpGaD
Propranolol—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	7.38e-05	0.000416	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	7.35e-05	0.000414	CbGpPWpGaD
Propranolol—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	7.33e-05	0.000413	CbGpPWpGaD
Propranolol—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	7.28e-05	0.00041	CbGpPWpGaD
Propranolol—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	7.23e-05	0.000407	CbGpPWpGaD
Propranolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	7.23e-05	0.000407	CbGpPWpGaD
Propranolol—HTR1B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	7.23e-05	0.000407	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	7.1e-05	0.0004	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	6.9e-05	0.000389	CbGpPWpGaD
Propranolol—HTR1A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	6.69e-05	0.000376	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	6.66e-05	0.000375	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	6.52e-05	0.000367	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	6.47e-05	0.000364	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	6.45e-05	0.000363	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	6.38e-05	0.000359	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	6.34e-05	0.000357	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	6.34e-05	0.000357	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	6.26e-05	0.000352	CbGpPWpGaD
Propranolol—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	6.26e-05	0.000352	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	6.24e-05	0.000351	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	6.22e-05	0.00035	CbGpPWpGaD
Propranolol—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	6.21e-05	0.00035	CbGpPWpGaD
Propranolol—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	6.17e-05	0.000347	CbGpPWpGaD
Propranolol—SLC22A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	6.16e-05	0.000347	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	6.05e-05	0.00034	CbGpPWpGaD
Propranolol—CYP1A1—PPARA activates gene expression—EP300—attention deficit hyperactivity disorder	6.02e-05	0.000339	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	6e-05	0.000338	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	5.92e-05	0.000334	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	5.9e-05	0.000332	CbGpPWpGaD
Propranolol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—attention deficit hyperactivity disorder	5.89e-05	0.000332	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	5.87e-05	0.000331	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	5.87e-05	0.00033	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	5.87e-05	0.00033	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	5.85e-05	0.00033	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	5.83e-05	0.000328	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	5.8e-05	0.000326	CbGpPWpGaD
Propranolol—ADRB1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	5.76e-05	0.000324	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	5.75e-05	0.000324	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	5.74e-05	0.000323	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	5.7e-05	0.000321	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	5.68e-05	0.00032	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	5.67e-05	0.000319	CbGpPWpGaD
Propranolol—ADRB2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	5.63e-05	0.000317	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	5.58e-05	0.000314	CbGpPWpGaD
Propranolol—HTR1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	5.5e-05	0.00031	CbGpPWpGaD
Propranolol—ADRB3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	5.48e-05	0.000309	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	5.45e-05	0.000307	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	5.3e-05	0.000299	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	5.29e-05	0.000298	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	5.19e-05	0.000292	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	5.18e-05	0.000292	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	5.15e-05	0.00029	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	5.15e-05	0.00029	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	5.13e-05	0.000289	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	5.07e-05	0.000286	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	5.07e-05	0.000285	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	5.05e-05	0.000284	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	5.05e-05	0.000284	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	5.04e-05	0.000284	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	5.02e-05	0.000283	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.98e-05	0.000281	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	4.98e-05	0.00028	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.95e-05	0.000279	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.95e-05	0.000279	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.94e-05	0.000278	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.94e-05	0.000278	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.93e-05	0.000278	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.91e-05	0.000277	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.88e-05	0.000275	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.84e-05	0.000273	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.83e-05	0.000272	CbGpPWpGaD
Propranolol—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	4.83e-05	0.000272	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.83e-05	0.000272	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	4.81e-05	0.000271	CbGpPWpGaD
Propranolol—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	4.79e-05	0.00027	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	4.79e-05	0.00027	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.77e-05	0.000268	CbGpPWpGaD
Propranolol—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	4.76e-05	0.000268	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.74e-05	0.000267	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	4.71e-05	0.000265	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	4.66e-05	0.000263	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	4.64e-05	0.000261	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.64e-05	0.000261	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	4.61e-05	0.000259	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	4.58e-05	0.000258	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.56e-05	0.000257	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	4.56e-05	0.000257	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	4.54e-05	0.000256	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	4.53e-05	0.000255	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.51e-05	0.000254	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	4.48e-05	0.000252	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	4.46e-05	0.000251	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	4.44e-05	0.00025	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	4.43e-05	0.000249	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	4.39e-05	0.000247	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	4.38e-05	0.000247	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	4.33e-05	0.000244	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.25e-05	0.000239	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	4.22e-05	0.000237	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.2e-05	0.000236	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	4.13e-05	0.000232	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	4.08e-05	0.00023	CbGpPWpGaD
Propranolol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	4.06e-05	0.000228	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—TPH2—attention deficit hyperactivity disorder	4.05e-05	0.000228	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.05e-05	0.000228	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—TPH2—attention deficit hyperactivity disorder	4.05e-05	0.000228	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.05e-05	0.000228	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	4.03e-05	0.000227	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.01e-05	0.000226	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—DPYD—attention deficit hyperactivity disorder	3.99e-05	0.000225	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—DPYD—attention deficit hyperactivity disorder	3.98e-05	0.000224	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.71e-05	0.000209	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	3.71e-05	0.000209	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.7e-05	0.000208	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.57e-05	0.000201	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.5e-05	0.000197	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	3.46e-05	0.000195	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.42e-05	0.000193	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	3.4e-05	0.000191	CbGpPWpGaD
Propranolol—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	3.36e-05	0.000189	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	3.36e-05	0.000189	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.35e-05	0.000188	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.28e-05	0.000185	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.25e-05	0.000183	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.24e-05	0.000183	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.24e-05	0.000182	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.2e-05	0.00018	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.18e-05	0.000179	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	3.13e-05	0.000176	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.11e-05	0.000175	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	3.09e-05	0.000174	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.09e-05	0.000174	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.08e-05	0.000173	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.06e-05	0.000172	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.02e-05	0.00017	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.99e-05	0.000168	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.95e-05	0.000166	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.94e-05	0.000166	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.93e-05	0.000165	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	2.93e-05	0.000165	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.93e-05	0.000165	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.89e-05	0.000163	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	2.88e-05	0.000162	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.84e-05	0.00016	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.82e-05	0.000159	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.78e-05	0.000157	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—TPH2—attention deficit hyperactivity disorder	2.77e-05	0.000156	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.77e-05	0.000156	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.75e-05	0.000155	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—DPYD—attention deficit hyperactivity disorder	2.72e-05	0.000153	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.72e-05	0.000153	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.71e-05	0.000152	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.69e-05	0.000152	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.68e-05	0.000151	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.67e-05	0.000151	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.65e-05	0.000149	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.63e-05	0.000148	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.62e-05	0.000147	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.59e-05	0.000146	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.56e-05	0.000144	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.56e-05	0.000144	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.53e-05	0.000143	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.49e-05	0.00014	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—COMT—attention deficit hyperactivity disorder	2.46e-05	0.000138	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—COMT—attention deficit hyperactivity disorder	2.45e-05	0.000138	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—MAOA—attention deficit hyperactivity disorder	2.44e-05	0.000137	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.44e-05	0.000137	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—MAOA—attention deficit hyperactivity disorder	2.44e-05	0.000137	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.38e-05	0.000134	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.34e-05	0.000132	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	2.27e-05	0.000128	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.27e-05	0.000128	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.23e-05	0.000126	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	2.23e-05	0.000126	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.21e-05	0.000125	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	2.21e-05	0.000125	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.21e-05	0.000125	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.19e-05	0.000123	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	2.18e-05	0.000123	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.11e-05	0.000119	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	2.08e-05	0.000117	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.08e-05	0.000117	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.07e-05	0.000117	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	2.05e-05	0.000115	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.02e-05	0.000114	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.97e-05	0.000111	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.91e-05	0.000107	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.81e-05	0.000102	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	1.78e-05	0.0001	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.77e-05	9.96e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	1.77e-05	9.94e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.77e-05	9.94e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	1.76e-05	9.93e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.74e-05	9.82e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	1.74e-05	9.78e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.72e-05	9.71e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.71e-05	9.61e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.68e-05	9.48e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—COMT—attention deficit hyperactivity disorder	1.68e-05	9.45e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.67e-05	9.4e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.67e-05	9.38e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—MAOA—attention deficit hyperactivity disorder	1.67e-05	9.38e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.62e-05	9.1e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.61e-05	9.09e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.59e-05	8.93e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.56e-05	8.77e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.41e-05	7.95e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	1.37e-05	7.73e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	1.36e-05	7.68e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	1.36e-05	7.67e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.36e-05	7.67e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.34e-05	7.57e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	1.34e-05	7.55e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	1.34e-05	7.55e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	1.33e-05	7.49e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.32e-05	7.44e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	1.26e-05	7.11e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	1.25e-05	7.06e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.25e-05	7.02e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.16e-05	6.53e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.09e-05	6.13e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	1.07e-05	6.02e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	1.06e-05	5.98e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—EP300—attention deficit hyperactivity disorder	1.05e-05	5.93e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—EP300—attention deficit hyperactivity disorder	1.05e-05	5.92e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.04e-05	5.84e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.03e-05	5.8e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	9.24e-06	5.2e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	9.04e-06	5.09e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.84e-06	4.98e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	8.26e-06	4.65e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	8.2e-06	4.62e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	7.62e-06	4.29e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—EP300—attention deficit hyperactivity disorder	7.19e-06	4.05e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	5.89e-06	3.32e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	5.75e-06	3.24e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	5.42e-06	3.05e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	4.59e-06	2.58e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	3.54e-06	1.99e-05	CbGpPWpGaD
